Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience to Provide Quest with Tag-It Reagents for Genetic Tests

NEW YORK, May 18 (GenomeWeb News) - Tm Bioscience will supply Quest Diagnostics with Tag-It reagents for genetic tests, the companies said yesterday.


Under the agreement, Tm Bioscience will initially provide its analyte specific reagents for eight genes. Mutations in these genes occur at a higher frequency in the Ashkenazi Jewish population.


The companies did not disclose any financial details.


Tm Bioscience's Tag-It assays use a proprietary tag system and operate on a Luminex xMap bead-based array system.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.